Tatiana Thula
Tatiana Thula is a healthcare professional associated with Novo Nordisk, where she serves as the coordinator for diabetes and rare diseases. In her role, she focuses on providing innovative and safe therapies for diabetes management and obesity treatment. Thula has recently been in the news for clarifying that the pricing strategy for medications like Ozempic, which has seen a reduction in the US, is specific to that market and does not extend to Guatemala or the region.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Guatemala:
Tatiana Thula explained that Novo Nordisk's pricing strategy is based on specific market analysis.
6